Related Experiment Videos
[Heterozygotic alpha-1 antitrypsin deficiency. A case report]
R Bataller Sifre1, R Vicente Ull, A Llombart Bosch
1Servicios de Medicina Interna (Grupo de Estudio Hepatobiliar, Hospital Clinico, Facultad de Medicina, Universidad de Valencia.
Summary
A patient with elevated liver enzymes was found to have alpha-1-antitrypsin deficiency (MZ phenotype). This suggests routine alpha-1-antitrypsin testing for chronic liver disease evaluation.
Area of Science:
- Hepatology
- Clinical Biochemistry
- Genetic Pathology
Background:
- Hypertransaminasemia, or elevated liver enzymes, can indicate underlying liver disease.
- Alpha-1-antitrypsin deficiency is a genetic disorder that can affect the liver and lungs.
Observation:
- A 34-year-old male presented with moderate hypertransaminasemia detected during a company screening.
- Analysis revealed an alpha-1-antitrypsin heterozygotic deficit (MZ phenotype), characterized by a flattened alpha wave on proteinogram and reduced serum levels.
- Liver biopsy showed no PAS-positive globules but did reveal rough endoplasmic reticulum (RER) dilatation with material deposition.
Findings:
- The patient's MZ phenotype for alpha-1-antitrypsin deficiency was confirmed through biochemical and electrophoretic analyses.
- Ultrastructural examination of the liver biopsy indicated RER dilatation, suggesting intracellular protein accumulation or processing abnormalities.
- The findings correlate the patient's specific phenotype with observed liver pathology, despite the absence of typical PAS-positive globules.
Implications:
- Routine serum alpha-1-antitrypsin level testing should be considered in the diagnostic workup of patients with unexplained chronic liver diseases.
- Understanding the spectrum of liver manifestations in alpha-1-antitrypsin deficiency is crucial for accurate diagnosis and management.
- This case highlights the importance of integrating clinical, biochemical, and histological data for comprehensive patient evaluation.